Preliminary Report on Stone Breakage and Lesion Size Produced by a New Extracorporeal Electrohydraulic (Sparker Array) Discharge Device - 28/05/18
, Ray B. Schaefer b, John J. Gallagher b, Cynthia D. Johnson a, Guangyan Li c, Rajash K. Handa a, Andrew P. Evan aAbstract |
Objective |
To determine if an innovative extracorporeal electrohydraulic shock wave (SW) device (sparker array [SPA]) can effectively fracture artificial stones in vitro and in vivo, and if SPA treatment produces a renal lesion in our pig model of lithotripsy injury. Results of these experiments will be used to help evaluate the suitability of this device as a clinical lithotripter.
Materials and Methods |
Ultracal-30 artificial stones were placed in a holder at the focus of the SPA and treated with 600 SWs (21.6 kV, 60 shocks/min). Stone fragments were collected, dried, and weighed to determine stone breakage. In vivo stone breakage entailed implanting stones into pigs. These stones were treated with 600 or 1200 SWs and the fragments were collected for analysis. Lesion analysis consisted of treating the left kidney of pigs with 1200 or 2400 SWs and quantitating the hemorrhagic lesion.
Results |
In vitro, 71% ± 2% of each artificial stone was fractured to <2 mm in size. In vivo stone breakage averaged 63%. Renal injury analysis revealed that only 1 of 7 kidneys showed evidence of hemorrhagic injury in the treated area.
Conclusion |
The SPA consistently comminuted artificial stones demonstrating its ability to fracture stones like other lithotripters. Also, the SPA caused little to no renal injury at the settings used in this study. These findings suggest further research is warranted to determine the potential of this device as a clinical lithotripter.
Le texte complet de cet article est disponible en PDF.Plan
| Financial Disclosure: Ray B. Schaefer and John J. Gallagher have a patent interest in sparker array technology. The remaining authors declare that they have no relevant financial interests. |
|
| Funding Support: This project was supported by National Institutes of Health grants R44 DK-089703 (Small Business Innovation Research) and P01 DK-43881. |
|
| Some of the data reported in this article have been previously published in abstract form (J Urol 2017; 197(4) supplement:e83). |
Vol 116
P. 213-217 - juin 2018 Retour au numéro
Article précédent
- Autologous Rectus Fascia Graft Interposition Repair of Urethrocutaneous Fistulae in Female-to-Male Metoidioplasty Patients
- Niels V. Johnsen, Bryan B. Voelzke
- Spina Bifida Health-care Guidelines for Men's Health
- John S. Wiener, Dominic C. Frimberger, Hadley Wood
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?